COMMUNIQUÉ DE PRESSE publié le 10/05/2024 à 08:00, il y a 5 mois 19 jours Press Release: Sanofi and Novavax announce co-exclusive licensing agreement to co-commercialize COVID-19 vaccine and develop novel flu-COVID-19 combination vaccines Sanofi and Novavax sign co-exclusive licensing agreement to co-commercialize COVID-19 vaccine & develop flu-COVID-19 combo vaccines. Agreement enhances patient access & protection. Details in press release COVID-19 Vaccine Licensing Agreement Sanofi Novavax Flu-COVID-19
Publié le 29/10/2024 à 17:40, il y a 10 heures 38 minutes Mersen to acquire Bar-Lo carbon products to consolidate its material strategy in the United States
Publié le 29/10/2024 à 17:40, il y a 10 heures 38 minutes Mersen acquiert Bar-Lo Carbon Products pour consolider sa stratégie matériaux aux États-Unis
Publié le 30/10/2024 à 01:15, il y a 3 heures 3 minutes LQWD Grants Incentive Stock Options to Key Management
Publié le 29/10/2024 à 22:10, il y a 6 heures 8 minutes Electric Metals Announces DSU and Stock Option Grant
Publié le 29/10/2024 à 20:15, il y a 8 heures 3 minutes Tenth Avenue Petroleum Executes Definitive Agreement To Acquire Low Decline, Production In Southern Alberta
Publié le 30/10/2024 à 00:17, il y a 4 heures EQS-Adhoc: Dexus Finance Pty Limited: September 2024 quarter update
Publié le 29/10/2024 à 23:56, il y a 4 heures 21 minutes grenke publishes preliminary figures for the third quarter of 2024
Publié le 29/10/2024 à 23:23, il y a 4 heures 54 minutes EQS-Adhoc: grenke reduces Group earnings guidance
Publié le 29/10/2024 à 20:34, il y a 7 heures 43 minutes EQS-Adhoc: Daimler Truck Holding AG: Release
Publié le 29/10/2024 à 19:08, il y a 9 heures 9 minutes Fuller, Smith & Turner PLC: Transaction in own shares
